Targeting microglia for the treatment of Alzheimer's disease.
about
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseaseCalcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's DiseaseHypertension, cerebrovascular impairment, and cognitive decline in aged AβPP/PS1 miceNeuroprotective Effect of Fagopyrum dibotrys Extract against Alzheimer's DiseaseTherapeutic potential of mGluR5 targeting in Alzheimer's diseaseImaging robust microglial activation after lipopolysaccharide administration in humans with PET.Overexpression of mitochondrial Hsp75 protects neural stem cells against microglia-derived soluble factor-induced neurotoxicity by regulating mitochondrial permeability transition pore opening in vitro.The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradationThromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury.Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation."Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.Masitinib for the treatment of mild to moderate Alzheimer's disease.Targeting specific cells in the brain with nanomedicines for CNS therapiesDifferent Molecular Mechanisms Mediate Direct or Glia-Dependent Prion Protein Fragment 90-231 Neurotoxic Effects in Cerebellar Granule Neurons.Inflammatory Response in the CNS: Friend or Foe?Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C.Capillarisin Suppresses Lipopolysaccharide-Induced Inflammatory Mediators in BV2 Microglial Cells by Suppressing TLR4-Mediated NF-κB and MAPKs Signaling Pathway.Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.Differential effect of intranasally administrated kinin B1 and B2 receptor antagonists in Alzheimer's disease mice.Effect of glycosides of Cistanche on the expression of mitochondrial precursor protein and keratin type II cytoskeletal 6A in a rat model of vascular dementia.Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis.Vaccination strategies in tauopathies and synucleinopathies.Microglia in the primate macula: specializations in microglial distribution and morphology with retinal position and with aging.The role of microglia in the progression of glaucomatous neurodegeneration- a review.Alzheimer's disease hypothesis and related therapies.MFG-E8 Selectively Inhibited Aβ-Induced Microglial M1 Polarization via NF-κB and PI3K-Akt Pathways.URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's disease.
P2860
Q26746050-8AE67862-BDA0-4194-8BFB-53304E478063Q26747527-F33DC330-AB31-4521-B8DD-4163C645E2FEQ33588229-8E5ACDB5-DD2C-4F85-B7F8-7E201A9514BEQ33634398-285C1021-65CC-445F-B885-7F1A5501CD4CQ35698522-D85C8CCD-73B7-447F-BF9F-1EB15FDDFAAFQ36155325-0EC9CFEC-40E1-4EAE-9EBA-EADF0992C752Q36369262-E872B176-2883-4ECA-8B99-5506808DCE32Q37085168-DAEEAFCB-C2C1-40DF-8129-7D1BAB34497DQ37360374-4DD6B481-A745-403E-9CD1-0931E3B7094FQ37510384-4532ACDB-D697-46F5-A9C4-B0BDA8CBBFD3Q38441500-B87A43C4-3098-44A1-AB8E-511EDA3E11C3Q38472067-9E70A102-AD60-46D7-ADE2-4ECDF90C3BD6Q38674279-BE8F38DC-C4FD-484C-89EC-4E8E420A12D5Q38765903-D9B04B94-18D8-431D-9474-DE4221AA6B8FQ38790379-AE5372C0-DF91-4F07-804E-A82061347FB6Q38793610-24599777-0C76-486C-9193-729CA0511952Q38884447-B3F9D96A-CE0C-4F3F-94C0-6E3CEF653FB5Q39249384-157617EE-DEB4-4F46-9C6E-C72C5693C0BCQ40334939-EC9C6E16-220D-44FB-8D1E-E864A56032A6Q41429905-AD3EADAE-52A6-4C53-B982-A6E012042564Q42327572-EAC5EF12-276E-45CD-AEF5-CA07AA8635B4Q47148054-834881D6-75DC-40C0-B5FB-68A552F53BE8Q47860105-27D2EBC9-9D70-4D45-86BF-4DE5658512DEQ48221388-418825DB-F4FD-47DA-B8BD-55369D56284EQ49192854-DAC4DE5F-DCCE-4DDE-88AF-522D4824F950Q49762112-B9BF7A32-ED5F-4539-9A00-E01C9344F517Q51065451-3C496D8B-5C07-4870-B569-E5C9B9492512Q54979695-F0395400-86C1-49F4-8FA6-9FA4D88EDBFE
P2860
Targeting microglia for the treatment of Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Targeting microglia for the treatment of Alzheimer's disease.
@en
type
label
Targeting microglia for the treatment of Alzheimer's disease.
@en
prefLabel
Targeting microglia for the treatment of Alzheimer's disease.
@en
P2860
P1476
Targeting microglia for the treatment of Alzheimer's disease.
@en
P2093
Edith G McGeer
Patrick L McGeer
P2860
P304
P356
10.1517/14728222.2014.988707
P407
P577
2014-11-29T00:00:00Z